POST-TEXT III and IV Hepatoblastoma
Authors:
- Seher CavdarSCSeher Cavdar
- Gunnar BlumenstockGBGunnar Blumenstock
- Martin EbingerMartin Ebinger
- Jürgen F. SchäferJSJürgen F. Schäfer
- Bence SiposBSBence Sipos
- Steven W. WarmannSWSteven W. Warmann
- 1 August 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 266 (2) , 318-323
Abstract
To analyze the outcome of hepatoblastoma (HB) patients presenting with post treatment extent of disease (POST-TEXT) stages III and IV after neoadjuvant chemotherapy. Primary liver transplantation has been advocated as surgical treatment for children with HB involving 3 or 4 sectors at diagnosis. However, in some cases, tumors seem resectable after chemotherapy through aggressive use of nontransplant surgical procedures. Data of 27 HB patients were reviewed, undergoing extended liver resection for POST-TEXT III or IV tumors after chemotherapy between 1992 and 2015. Median follow-up was 58 months (range 9–188). Median age at surgery was 18.2 months (interquartile range 10.8–32.5). Staging of the children after chemotherapy revealed POST-TEXT III in 21 and POST-TEXT IV in 6 cases. In 2 children, the hepatic resection was performed under cardiopulmonary bypass because of extended vena cava thrombosis; in 2 patients, a simultaneous sternotomy was performed for resection of bilateral lung metastases. The 5-year overall survival rate was 80.7%. Aggressive surgical resection is a successful approach in some patients with POST-TEXT III and IV HB who otherwise would be candidates for liver transplantation. These children should undergo central review and should be surgically managed at centers of excellence for pediatric liver surgery. Despite challenging surgical procedures and complex clinical courses, the patients benefit from avoidance of morbidities of organ transplant. However, preparation of backup liver transplantation should be considered in selected cases.Keywords
This publication has 28 references indexed in Scilit:
- State of the art in oncology: High risk neuroblastoma, alveolar rhabdomyosarcoma, desmoplastic small round cell tumor, and POST-TEXT 3 and 4 hepatoblastomaJournal of Pediatric Surgery, 2014
- Role of liver transplantation in the management of hepatoblastoma in the pediatric populationWorld Journal of Transplantation, 2014
- Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility studyThe Lancet Oncology, 2013
- Successful nontransplant resection of POST‐TEXT III and IV hepatoblastomaCancer, 2010
- High-Risk Hepatoblastoma: Results in a Pediatric Liver Transplantation CenterEuropean Journal of Pediatric Surgery, 2010
- Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLTPediatric Surgery International, 2010
- Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR StudyJournal of Clinical Oncology, 2010
- 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL groupPediatric Radiology, 2006
- Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results From the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 StudyJournal of Clinical Oncology, 2005
- Differenzierte Therapieansätze für Hoch- und Standardrisiko-HepatoblastomeKlinische Padiatrie, 2003